ARGNF
Price
$569.19
Change
-$17.35 (-2.96%)
Updated
Jun 24 closing price
Capitalization
34.11B
GNNSF
Price
$2.20
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Capitalization
4.02B
Interact to see
Advertisement

ARGNF vs GNNSF

Header iconARGNF vs GNNSF Comparison
Open Charts ARGNF vs GNNSFBanner chart's image
Argen X
Price$569.19
Change-$17.35 (-2.96%)
Volume$2
Capitalization34.11B
Genscript Biotech
Price$2.20
Change-$0.00 (-0.00%)
Volume$500
Capitalization4.02B
ARGNF vs GNNSF Comparison Chart in %
Loading...
ARGNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARGNF vs. GNNSF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARGNF is a Buy and GNNSF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ARGNF: $569.19 vs. GNNSF: $2.20)
Brand notoriety: ARGNF and GNNSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARGNF: 18% vs. GNNSF: 60%
Market capitalization -- ARGNF: $34.11B vs. GNNSF: $4.02B
ARGNF [@Biotechnology] is valued at $34.11B. GNNSF’s [@Biotechnology] market capitalization is $4.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARGNF’s FA Score shows that 1 FA rating(s) are green whileGNNSF’s FA Score has 0 green FA rating(s).

  • ARGNF’s FA Score: 1 green, 4 red.
  • GNNSF’s FA Score: 0 green, 5 red.
According to our system of comparison, ARGNF is a better buy in the long-term than GNNSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARGNF’s TA Score shows that 3 TA indicator(s) are bullish while GNNSF’s TA Score has 4 bullish TA indicator(s).

  • ARGNF’s TA Score: 3 bullish, 1 bearish.
  • GNNSF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ARGNF and GNNSF are a good buy in the short-term.

Price Growth

ARGNF (@Biotechnology) experienced а -2.96% price change this week, while GNNSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARGNF($34.1B) has a higher market cap than GNNSF($4.03B). GNNSF YTD gains are higher at: 73.228 vs. ARGNF (-12.747).
ARGNFGNNSFARGNF / GNNSF
Capitalization34.1B4.03B847%
EBITDA365MN/A-
Gain YTD-12.74773.228-17%
P/E Ratio34.71N/A-
Revenue2.58BN/A-
Total Cash3.38BN/A-
Total Debt39.1MN/A-
FUNDAMENTALS RATINGS
ARGNF vs GNNSF: Fundamental Ratings
ARGNF
GNNSF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
1199
SMR RATING
1..100
5097
PRICE GROWTH RATING
1..100
5735
P/E GROWTH RATING
1..100
9048
SEASONALITY SCORE
1..100
6285

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARGNF's Valuation (74) in the null industry is in the same range as GNNSF (94). This means that ARGNF’s stock grew similarly to GNNSF’s over the last 12 months.

ARGNF's Profit vs Risk Rating (11) in the null industry is significantly better than the same rating for GNNSF (99). This means that ARGNF’s stock grew significantly faster than GNNSF’s over the last 12 months.

ARGNF's SMR Rating (50) in the null industry is somewhat better than the same rating for GNNSF (97). This means that ARGNF’s stock grew somewhat faster than GNNSF’s over the last 12 months.

GNNSF's Price Growth Rating (35) in the null industry is in the same range as ARGNF (57). This means that GNNSF’s stock grew similarly to ARGNF’s over the last 12 months.

GNNSF's P/E Growth Rating (48) in the null industry is somewhat better than the same rating for ARGNF (90). This means that GNNSF’s stock grew somewhat faster than ARGNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARGNFGNNSF
RSI
ODDS (%)
Bullish Trend 3 days ago
20%
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
39%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
12%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
19%
Bullish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
27%
Bullish Trend 3 days ago
59%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
61%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ARGNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DUSB50.730.04
+0.08%
Dimensional Ultrashort Fixed Income ETF
COMB21.100.01
+0.06%
GraniteShares Blmbrg CmdtyBrdStr NoK1ETF
CPNJ26.14N/A
+0.01%
Calamos Nasdaq-100 Str Alt Prt ETF-Jun
TDF10.04-0.01
-0.10%
Templeton Dragon Fund
BNDD12.40-0.08
-0.66%
Quadratic Deflation ETF

ARGNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGNF has been loosely correlated with SLS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGNF jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGNF
1D Price
Change %
ARGNF100%
N/A
SLS - ARGNF
36%
Loosely correlated
-3.94%
RLMD - ARGNF
31%
Poorly correlated
N/A
TPST - ARGNF
27%
Poorly correlated
-2.68%
GNNSF - ARGNF
23%
Poorly correlated
N/A
CVALF - ARGNF
23%
Poorly correlated
N/A
More

GNNSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNNSF has been loosely correlated with SILO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GNNSF jumps, then SILO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
SILO - GNNSF
42%
Loosely correlated
+1.52%
SCNI - GNNSF
26%
Poorly correlated
-7.69%
CORT - GNNSF
25%
Poorly correlated
-1.49%
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
More